Clinical Trials Directory

Trials / Completed

CompletedNCT01525797

Blood Draw Study for Liver Transplant Patients

Immunomonitoring of Transplant Patients

Status
Completed
Phase
Study type
Observational
Enrollment
221 (actual)
Sponsor
Baylor Research Institute · Academic / Other
Sex
All
Age
17 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Detailed description

The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.

Conditions

Timeline

Start date
2002-10-15
Primary completion
2013-10-04
Completion
2013-10-04
First posted
2012-02-03
Last updated
2026-01-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01525797. Inclusion in this directory is not an endorsement.